Center of Excellence for ADHD and Related Disorders
Does your child have difficulty focusing at school or at home?
Does he or she have trouble listening and following directions?
Does he or she have a hard time sitting still and is constantly on the go?
The Division of ADHD and Learning Disorders at Icahn School of Medicine at Mount Sinai is seeking children and adolescents, ages 7 to 17, with suspected or diagnosed ADHD to participate in a study examining response to methylphenidate or atomoxetine. Both are commonly prescribed medications that are FDA approved for the treatment of ADHD in children.
Participation in this research study involves:
- An initial evaluation for ADHD
- Weekly doctor visits for 6 to 8 weeks to determine the best dose for your child
- Non-invasive fMRI scanning while your child plays a video game
- (Reimbursement is provided)
For more information, contact Beth Krone, PhD, at 212-241-8012 or firstname.lastname@example.org.